Black Rock Inc. Biodesix Inc Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Biodesix Inc stock. As of the latest transaction made, Black Rock Inc. holds 415,908 shares of BDSX stock, worth $3.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

415,908

Previous 402,908 3.23%

Holding current value

$3.33 Million

Previous $576,000 10.42%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.21 - $1.71 $15,730 - $22,230	13,000 Added 3.23%	415,908 $636,000
Q1 2024 May 10, 2024	SELL	$1.35 - $2.12 $2,096 - $3,292	-1,553 Reduced 0.38%	402,908 $576,000
Q4 2023 Feb 13, 2024	BUY	$1.2 - $2.13 $4,966 - $8,816	4,139 Added 1.03%	404,461 $744,000
Q3 2023 Nov 13, 2023	SELL	$1.04 - $1.74 $9,481 - $15,863	-9,117 Reduced 2.23%	400,322 $660,000
Q2 2023 Aug 11, 2023	BUY	$1.12 - $1.88 $10,524 - $17,666	9,397 Added 2.35%	409,439 $503,000
Q1 2023 May 12, 2023	BUY	$1.52 - $2.5 $547,069 - $899,785	359,914 Added 896.91%	400,042 $744,000
Q4 2022 Feb 13, 2023	BUY	$0.98 - $2.3 $815 - $1,913	832 Added 2.12%	40,128 $92,000
Q3 2022 Nov 14, 2022	BUY	$1.24 - $2.89 $2,548 - $5,938	2,055 Added 5.52%	39,296 $50,000
Q2 2022 Aug 12, 2022	SELL	$1.32 - $2.12 $702,709 - $1.13 Million	-532,356 Reduced 93.46%	37,241 $61,000
Q1 2022 May 12, 2022	SELL	$1.69 - $5.81 $12,920 - $44,417	-7,645 Reduced 1.32%	569,597 $962,000
Q4 2021 Feb 10, 2022	BUY	$4.09 - $8.67 $24,826 - $52,626	6,070 Added 1.06%	577,242 $3.05 Million
Q3 2021 Nov 09, 2021	SELL	$6.6 - $12.78 $16,909 - $32,742	-2,562 Reduced 0.45%	571,172 $4.7 Million
Q2 2021 Aug 11, 2021	BUY	$12.14 - $20.35 $6.97 Million - $11.7 Million	573,734 New	573,734 $7.58 Million

Others Institutions Holding BDSX

# of Institutions

Shares Held

1.14M

Call Options Held

Put Options Held

View Full List

About BIODESIX INC

Ticker BDSX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 39,982,000
Market Cap $320M
Description
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...

More about BDSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account